Efficacy of Golimumab in Maintaining Deep Remission in UC Patients in Prolonged Remission With Infliximab

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
This study monitors the efficacy and safety of Golimumab in maintaining deep remission and quality of life in Ulcerative Colitis patients in deep prolonged remission with Infliximab. Patients will be followed up for one year and they will be assessed with biochemical tests (C-Reactive Protein , Full Blood Count , Faecal Calprotectin),endoscopic evaluation (MAYO Score) and finally histologically.
Epistemonikos ID: f440228331669dcb0bd732b4a9d769ddeec91a90
First added on: May 17, 2024